Internal Medicine, Gastroenterology · Shenandoah, TX
NPI
1023093481
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
129 Vision Park Blvd, # 307
Shenandoah, TX, 77384
Phone (936) 321-5440
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
1,057 services
Medicare patients, 2024
337
Average age 73
Drug cost, 2024
$1.1M
1,866 prescriptions
Company payments, 2025
$2,770
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter R Kvapil was code 99214 (office e&m - established), 193 times for 147 patients. In total Peter R Kvapil billed 1,057 services in 37 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 193 | 147 | $75.45 | $15K |
| 45380 Lower GI Endoscopy - Other | Facility | 112 | 112 | $108.10 | $12K |
| 43239 Upper GI Endoscopy | Facility | 109 | 106 | $58.20 | $6,344 |
| 99213 Office E&M - Established | Office | 68 | 67 | $43.50 | $2,958 |
| 99203 Office E&M - New | Office | 45 | 45 | $48.60 | $2,187 |
| 99204 Office E&M - New | Office | 37 | 37 | $101.73 | $3,764 |
| 45385 Colonoscopy - Lesion Removal | Facility | 26 | 26 | $172.37 | $4,482 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 19 | 19 | $156.99 | $2,983 |
| 91200 Standard X-ray | Office | 14 | 14 | $20.92 | $293 |
| 87507 Infectious Agent Detection by DNA/RNA | Office | 14 | 14 | $408.44 | $5,718 |
| 76981 Ultrasound - Nonspecific | Office | 14 | 13 | $66.39 | $929 |
| 99202 Office E&M - New | Office | 13 | 13 | $30.64 | $398 |
| 45378 Lower GI Endoscopy - Other | Facility | 12 | 12 | $118.49 | $1,422 |
By year: 2022 $82K for 839 services; 2023 $119K for 3,860 services; 2024 $72K for 1,057 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87507 Infectious Agent Detection by DNA/RNA | 14 | 14 | $408.44 | $5,718 |
Medicare prescription drug claims, 2024
In 2024, the drug Peter R Kvapil prescribed most often to Medicare patients was Pantoprazole Sodium, with 470 prescriptions and refills. In total Peter R Kvapil wrote 1,866 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 470 | 1,122 | 157 | $6,599 |
| Famotidine Generic | 240 | 582 | 79 | $3,095 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 123 | 123 | 122 | $7,592 |
| Omeprazole Generic | 97 | 266 | 36 | $1,486 |
| Esomeprazole Magnesium Generic | 78 | 198 | 28 | $5,416 |
| Sucralfate Generic | 48 | 101 | 16 | $1,578 |
| Ursodiol Generic | 47 | 95 | 11 | $7,826 |
| Creon Lipase/Protease/Amylase | 45 | 73 | 17 | $184K |
| Ondansetron Odt Ondansetron | 39 | 49 | 13 | $883 |
| Nystatin Generic | 34 | 34 | 27 | $765 |
| Dicyclomine Hcl Generic | 34 | 37 | 12 | $458 |
| Mesalamine Generic | 34 | 66 | Under 11 | $11K |
| Dexlansoprazole Dr Dexlansoprazole | 32 | 74 | Under 11 | $11K |
| Linzess Linaclotide | 28 | 52 | Under 11 | $27K |
| Colestipol Hcl Generic | 27 | 70 | 12 | $2,463 |
Brand drugs: 304 claims; generic drugs: 1,562 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter R Kvapil $2,770 ($2,770 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $926.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 51 | $926 |
| Janssen Biotech, Inc. JNJ | 16 | $354 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 10 | $308 |
| QOL Medical, LLC | 10 | $192 |
| Lilly USA, LLC LLY | 3 | $178 |
| Medtronic, Inc. MDT | 1 | $164 |
| Phathom Pharmaceuticals, Inc. PHAT | 7 | $156 |
| Genzyme Corporation SNY | 4 | $113 |
| Gilead Sciences, Inc. GILD | 4 | $87.91 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $67.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.